February 13, 2020 / 12:23 PM / 16 days ago

BRIEF-Blueprint Medicines Reports Q4 Loss Per Share Of $1.35

Feb 13 (Reuters) - Blueprint Medicines Corp:

* BLUEPRINT MEDICINES REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $1.35

* Q4 EARNINGS PER SHARE ESTIMATE $-1.69 — REFINITIV IBES DATA

* QUARTERLY COLLABORATION REVENUE $51.5 MILLION VERSUS $1.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below